The nation of Zimbabwe has declined a substantial US healthcare agreement worth 367 million US dollars (£272m) over five years over the United States' request for confidential information.
The decision came to light following a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
An official representative later explained that the United States was seeking biological samples for research and commercial purposes while was unwilling to guarantee the benefits from any future vaccines.
"We must now begin the challenging and unfortunate process of ending our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for continued dialogue to find a agreement agreeable to both sides so the country's critical HIV programme can be sustained.
Wider Context
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court halted a similar health funding agreement following concerns were raised about the security of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered aid for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and responsibility.
According to reports, 16 nations in Africa have so far signed these new agreements, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," his statement read.
"Put simply, our country would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our people should a new pandemic arise."
National Interest and International Frameworks
He also pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were upending structures previously set up via the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with future pandemics.
"This framework is intended to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to create them."
These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage further discussions with our American counterparts on how subsequent co-operation could be arranged in a way that respects the independence and dignity of both nations."
Medical Community Reaction
Medical experts stated it acknowledged the government's concerns, but recommended that negotiations must proceed considering a large portion of the country's HIV programmes depended on foreign aid.
"In cases where specific concerns arise, such as those relating to information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," it added.
The situation emphasises the continuing challenges between receiving crucial international aid and protecting national sovereignty in an ever more interconnected world.